For years, scientists have hoped to use the gene-editing technology CRISPR to help treat all sorts of diseases, including cancer. Now for the first time in the U.S., researchers say they’ve shown that CRISPR-edited immune cells can be safely given to cancer patients and survive for up to nine months—a…
An alarming study that added fuel to the fire over a recent controversial genetic experiment in China has now been invalidated. The study, which suggested that a mutation induced by Chinese scientist He Jiankui in human babies could shorten their lives, was retracted late last week, after other scientists failed to…
Now you can get the top stories from Gizmodo delivered to your inbox. Enter your email below.
By subscribing you agree to our Terms of Use and Privacy Policy.